GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Pathlab & Diagnostics Ltd (BOM:540788) » Definitions » Total Equity

Aspira Pathlab & Diagnostics (BOM:540788) Total Equity : ₹111.8 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Aspira Pathlab & Diagnostics Total Equity?

Aspira Pathlab & Diagnostics's total equity for the quarter that ended in Sep. 2024 was ₹111.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Aspira Pathlab & Diagnostics Total Equity Historical Data

The historical data trend for Aspira Pathlab & Diagnostics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Pathlab & Diagnostics Total Equity Chart

Aspira Pathlab & Diagnostics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.01 83.15 127.89 127.50 101.43

Aspira Pathlab & Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.24 - 101.43 - 111.80

Aspira Pathlab & Diagnostics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Aspira Pathlab & Diagnostics's Total Equity for the fiscal year that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=147.096-45.663
=101.4

Aspira Pathlab & Diagnostics's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=158.222-46.42
=111.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspira Pathlab & Diagnostics Total Equity Related Terms

Thank you for viewing the detailed overview of Aspira Pathlab & Diagnostics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspira Pathlab & Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (west), Mumbai, MH, IND, 400086
Aspira Pathlab & Diagnostics Ltd is an India based company engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. Geographically, it operates only in India.

Aspira Pathlab & Diagnostics Headlines

No Headlines